A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Trasplante de la médula ósea; Trasplante de células madre; Trasplante de células madre hematopoyéticas; Trasplante no mieloablativo de intensidad reducida; Mini trasplante; Alotrasplante de médula ósea; Autotrasplante de médula ósea; Trasplante de sangre del cordón umbilical
Un trasplante de médula ósea puede causar los siguientes síntomas:
Las posibles complicaciones de un trasplante de médula ósea dependen de muchos factores, como:
Las complicaciones puede abarcar:
Bishop MR, Pavletic SZ. Hematopoietic stem cell transplantation. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKena WG, eds. Clinical Oncology. 4th ed. Philadelphia, Pa: Elsevier Churchill Livingstone; 2008:chap 32.
Vose JM, Pavletic SZ. Hematopoietic stem cell transplantation. In: Goldman L, Ausiello D. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 184.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885